Multicenter phase II trial of first-line irinotecan (CPT-11) and gemcitabine (GMB) in patients with unresectable pancreatic cancer
Stathopoulos, G., Rigatos, S., Androulakis, N., Souglakos, J., Kouroussis, Ch., Dimopoulos, A.M., Aravantinos, G., Giannakakis, Th., Foutzilas, G., Stathopoulos, J., Georgoulias, V.Volume:
37
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(01)81648-8
Date:
April, 2001
File:
PDF, 198 KB
english, 2001